215 related articles for article (PubMed ID: 27541716)
1. Loss-of-function polymorphisms in the organic cation transporter OCT1 are associated with reduced postoperative tramadol consumption.
Stamer UM; Musshoff F; Stüber F; Brockmöller J; Steffens M; Tzvetkov MV
Pain; 2016 Nov; 157(11):2467-2475. PubMed ID: 27541716
[TBL] [Abstract][Full Text] [Related]
2. Genetically polymorphic OCT1: another piece in the puzzle of the variable pharmacokinetics and pharmacodynamics of the opioidergic drug tramadol.
Tzvetkov MV; Saadatmand AR; Lötsch J; Tegeder I; Stingl JC; Brockmöller J
Clin Pharmacol Ther; 2011 Jul; 90(1):143-50. PubMed ID: 21562485
[TBL] [Abstract][Full Text] [Related]
3. Concentrations of tramadol and O-desmethyltramadol enantiomers in different CYP2D6 genotypes.
Stamer UM; Musshoff F; Kobilay M; Madea B; Hoeft A; Stuber F
Clin Pharmacol Ther; 2007 Jul; 82(1):41-7. PubMed ID: 17361124
[TBL] [Abstract][Full Text] [Related]
4. SLC22A1/OCT1 Genotype Affects O-desmethyltramadol Exposure in Newborn Infants.
Matic M; de Wildt SN; Elens L; de Hoon JN; Annaert P; Tibboel D; van Schaik RH; Allegaert K
Ther Drug Monit; 2016 Aug; 38(4):487-92. PubMed ID: 27082504
[TBL] [Abstract][Full Text] [Related]
5. Effect of the CYP2D6*10 C188T polymorphism on postoperative tramadol analgesia in a Chinese population.
Wang G; Zhang H; He F; Fang X
Eur J Clin Pharmacol; 2006 Nov; 62(11):927-31. PubMed ID: 16960721
[TBL] [Abstract][Full Text] [Related]
6. Impact of CYP2D6 genotype on postoperative tramadol analgesia.
Stamer UM; Lehnen K; Höthker F; Bayerer B; Wolf S; Hoeft A; Stuber F
Pain; 2003 Sep; 105(1-2):231-8. PubMed ID: 14499440
[TBL] [Abstract][Full Text] [Related]
7. OCT1 pharmacogenetics in pain management: is a clinical application within reach?
Tzvetkov MV
Pharmacogenomics; 2017 Nov; 18(16):1515-1523. PubMed ID: 29061087
[TBL] [Abstract][Full Text] [Related]
8. Effect of the CYP2D6 gene polymorphism on postoperative analgesia of tramadol in Han nationality nephrectomy patients.
Dong H; Lu SJ; Zhang R; Liu DD; Zhang YZ; Song CY
Eur J Clin Pharmacol; 2015 Jun; 71(6):681-686. PubMed ID: 25948472
[TBL] [Abstract][Full Text] [Related]
9. Effect of the cytochrome P450 2D6*10 genotype on the pharmacokinetics of tramadol in post-operative patients.
Xu J; Zhang XC; Lv XQ; Xu YY; Wang GX; Jiang B; Cai L; Cai XJ
Pharmazie; 2014 Feb; 69(2):138-41. PubMed ID: 24640604
[TBL] [Abstract][Full Text] [Related]
10. Effects of the CYP2D6 gene duplication on the pharmacokinetics and pharmacodynamics of tramadol.
Kirchheiner J; Keulen JT; Bauer S; Roots I; Brockmöller J
J Clin Psychopharmacol; 2008 Feb; 28(1):78-83. PubMed ID: 18204346
[TBL] [Abstract][Full Text] [Related]
11. Tramadol efficacy in patients with postoperative pain in relation to CYP2D6 and MDR1 polymorphisms.
Slanar O; Dupal P; Matouskova O; Vondrackova H; Pafko P; Perlik F
Bratisl Lek Listy; 2012; 113(3):152-5. PubMed ID: 22428763
[TBL] [Abstract][Full Text] [Related]
12. Antagonistic effects of ondansetron and tramadol? A randomized placebo and active drug controlled study.
Rauers NI; Stüber F; Lee EH; Musshoff F; Fimmers R; Barann M; Stamer UM
J Pain; 2010 Dec; 11(12):1274-81. PubMed ID: 20488759
[TBL] [Abstract][Full Text] [Related]
13. A rapid and simple CYP2D6 genotyping assay--case study with the analgetic tramadol.
Borlak J; Hermann R; Erb K; Thum T
Metabolism; 2003 Nov; 52(11):1439-43. PubMed ID: 14624403
[TBL] [Abstract][Full Text] [Related]
14. Post-mortem SNP analysis of CYP2D6 gene reveals correlation between genotype and opioid drug (tramadol) metabolite ratios in blood.
Levo A; Koski A; Ojanperä I; Vuori E; Sajantila A
Forensic Sci Int; 2003 Jul; 135(1):9-15. PubMed ID: 12893130
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6) are associated with long term tramadol treatment-induced oxidative damage and hepatotoxicity.
Arafa MH; Atteia HH
Toxicol Appl Pharmacol; 2018 May; 346():37-44. PubMed ID: 29555325
[TBL] [Abstract][Full Text] [Related]
16. Impact of CYP genotype and inflammatory markers on the plasma concentrations of tramadol and its demethylated metabolites and drug tolerability in cancer patients.
Tanaka H; Naito T; Sato H; Hiraide T; Yamada Y; Kawakami J
Eur J Clin Pharmacol; 2018 Nov; 74(11):1461-1469. PubMed ID: 30051214
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetic aspects of tramadol pharmacokinetics and pharmacodynamics after a single oral dose.
Bastami S; Haage P; Kronstrand R; Kugelberg FC; Zackrisson AL; Uppugunduri S
Forensic Sci Int; 2014 May; 238():125-32. PubMed ID: 24709712
[TBL] [Abstract][Full Text] [Related]
18. Enantiomeric determination of tramadol and O-desmethyltramadol by liquid chromatography- mass spectrometry and application to postoperative patients receiving tramadol.
Musshoff F; Madea B; Stuber F; Stamer UM
J Anal Toxicol; 2006 Sep; 30(7):463-7. PubMed ID: 16959140
[TBL] [Abstract][Full Text] [Related]
19. Population pharmacokinetic analysis of tramadol and
Lee J; Yoo HD; Bae JW; Lee S; Shin KH
Drug Des Devel Ther; 2019; 13():1751-1761. PubMed ID: 31213765
[No Abstract] [Full Text] [Related]
20. Population pharmacokinetic modeling of tramadol and its O-desmethyl metabolite in plasma and breast milk.
Salman S; Sy SK; Ilett KF; Page-Sharp M; Paech MJ
Eur J Clin Pharmacol; 2011 Sep; 67(9):899-908. PubMed ID: 21394525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
